BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 20694910)

  • 1. The recipe for overreaching regulation.
    Schwab A
    Am J Bioeth; 2010 Aug; 10(8):55-6. PubMed ID: 20694910
    [No Abstract]   [Full Text] [Related]  

  • 2. Striking the right balance in research ethics and regulation.
    Miller FG
    Am J Bioeth; 2010 Aug; 10(8):65. PubMed ID: 20694916
    [No Abstract]   [Full Text] [Related]  

  • 3. Reversing "research exceptionalism".
    Hansson SO
    Am J Bioeth; 2010 Aug; 10(8):66-7. PubMed ID: 20694917
    [No Abstract]   [Full Text] [Related]  

  • 4. Assessing the case for the regulation of research.
    Wilkinson T
    Am J Bioeth; 2010 Aug; 10(8):63-5. PubMed ID: 20694915
    [No Abstract]   [Full Text] [Related]  

  • 5. Pragmatism as a complementary approach to legislation: closing regulatory gaps in human subject research.
    Vernillo A
    Am J Bioeth; 2008 Nov; 8(11):15-7. PubMed ID: 19061099
    [No Abstract]   [Full Text] [Related]  

  • 6. Not all human subjects research is exceptional.
    Moffatt B
    Am J Bioeth; 2010 Aug; 10(8):62-3. PubMed ID: 20694914
    [No Abstract]   [Full Text] [Related]  

  • 7. Responses to open peer commentaries on "research exceptionalism".
    Hunter D; Wilson J
    Am J Bioeth; 2010 Aug; 10(8):W4-6. PubMed ID: 20694896
    [No Abstract]   [Full Text] [Related]  

  • 8. To expedite or not to expedite ...that is the question.
    Wicher CC; Michalek AM
    J Cancer Educ; 2008; 23(3):140-1. PubMed ID: 18709583
    [No Abstract]   [Full Text] [Related]  

  • 9. Research involving children: regulations, review boards and reform.
    Gandhi R
    J Health Care Law Policy; 2005; 8(2):264-330. PubMed ID: 16471026
    [No Abstract]   [Full Text] [Related]  

  • 10. Closing loopholes in the federal research regulations: some practical problems.
    Resnik DB
    Am J Bioeth; 2008 Nov; 8(11):6-8. PubMed ID: 19061095
    [No Abstract]   [Full Text] [Related]  

  • 11. The basics of human subjects protection.
    Yoder LH
    Medsurg Nurs; 2006 Apr; 15(2):95-8; quiz 99. PubMed ID: 16700248
    [No Abstract]   [Full Text] [Related]  

  • 12. The flip of the coin: exempt, expedited, or full IRB review?
    Bliss-Holtz J
    AACN Adv Crit Care; 2007; 18(2):213-7. PubMed ID: 17473550
    [No Abstract]   [Full Text] [Related]  

  • 13. One size does not fit all: the ethical imperative to limit the concept of research exceptionalism.
    McCullough M
    Am J Bioeth; 2010 Aug; 10(8):60-1. PubMed ID: 20694913
    [No Abstract]   [Full Text] [Related]  

  • 14. Not all research is equal: taking social science research into account.
    Rasmussen LM
    Am J Bioeth; 2008 Nov; 8(11):17-8. PubMed ID: 19061100
    [No Abstract]   [Full Text] [Related]  

  • 15. Research exceptionalism.
    Wilson J; Hunter D
    Am J Bioeth; 2010 Aug; 10(8):45-54. PubMed ID: 20694909
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A response to commentators on "Universal and uniform protections of human subjects in research".
    Shamoo AE; Schwartz J
    Am J Bioeth; 2008 Nov; 8(11):W1. PubMed ID: 19061093
    [No Abstract]   [Full Text] [Related]  

  • 17. Are human research subjects safe enough?
    Thompson RE
    Physician Exec; 2003; 29(4):52-4. PubMed ID: 14650072
    [No Abstract]   [Full Text] [Related]  

  • 18. Improving protection for human research subjects: better oversight, not just more oversight.
    Schluger NW
    Am J Bioeth; 2008 Nov; 8(11):13-5. PubMed ID: 19061098
    [No Abstract]   [Full Text] [Related]  

  • 19. Reform of Clinical Research Regulations, Finally.
    Emanuel EJ
    N Engl J Med; 2015 Dec; 373(24):2296-9. PubMed ID: 26536071
    [No Abstract]   [Full Text] [Related]  

  • 20. Research firm changes subject notification procedure after complaint by potential subject.
    Maloney DM
    Hum Res Rep; 2002 Nov; 17(11):6-7. PubMed ID: 12708413
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.